These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


335 related items for PubMed ID: 30596221

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.
    Franceschi J, Ehret M, Visseaux L, Durlach A, Barbe C, Durot É, Grange F.
    Acta Derm Venereol; 2022 Mar 22; 102():adv00676. PubMed ID: 35083494
    [Abstract] [Full Text] [Related]

  • 3. Mycosis fungoides and the Sézary syndrome.
    Foss F.
    Curr Opin Oncol; 2004 Sep 22; 16(5):421-8. PubMed ID: 15314509
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK, McCormack C, Wells J, Campbell BA, Newland K, Lade S, Buelens O, Joske D, Shortt J, Mapp S, Radeski D, Hertzberg M, Khot A, Van Der Weyden C, Khoo C, Hawkes E, Prince HM.
    Australas J Dermatol; 2021 Feb 22; 62(1):e8-e18. PubMed ID: 33368169
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mycosis fungoides: pathophysiology and emerging therapies.
    Duvic M, Foss FM.
    Semin Oncol; 2007 Dec 22; 34(6 Suppl 5):S21-8. PubMed ID: 18086343
    [Abstract] [Full Text] [Related]

  • 17. State of the art therapy of mycosis fungoides and Sézary syndrome.
    Kemme DJ, Bunn PA.
    Oncology (Williston Park); 1992 Feb 22; 6(2):31-42; discussion 44, 47-8. PubMed ID: 1532501
    [Abstract] [Full Text] [Related]

  • 18. Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.
    Joshi TP, Duvic M.
    J Am Acad Dermatol; 2023 Jun 22; 88(6):e305-e306. PubMed ID: 36858155
    [No Abstract] [Full Text] [Related]

  • 19. Mycosis fungoides and the Sézary syndrome.
    Kim YH, Hoppe RT.
    Semin Oncol; 1999 Jun 22; 26(3):276-89. PubMed ID: 10375085
    [Abstract] [Full Text] [Related]

  • 20. Cutaneous Lymphomas - Part I: Mycosis Fungoides, Sézary Syndrome, and CD30+ Cutaneous Lymphoproliferative Disorders.
    Pujol RM, Gallardo F.
    Actas Dermosifiliogr (Engl Ed); 2021 Jan 22; 112(1):14-23. PubMed ID: 32896500
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.